207 related articles for article (PubMed ID: 9660)
1. Mepiprazole, a new psychotropic drug: effects on uptake and retention of monoamines in rat brain synaptosomes.
Placheta P; Singer E; Kriwanek W; Hertting G
Psychopharmacology (Berl); 1976 Aug; 48(3):295-301. PubMed ID: 9660
[TBL] [Abstract][Full Text] [Related]
2. Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes.
Bolden-Watson C; Richelson E
Life Sci; 1993; 52(12):1023-9. PubMed ID: 8445992
[TBL] [Abstract][Full Text] [Related]
3. Neurochemical characterization of a new potent and selective serotonin uptake inhibitor: Lu 10-171.
Hyttel J
Psychopharmacology (Berl); 1977 Mar; 51(3):225-33. PubMed ID: 403537
[TBL] [Abstract][Full Text] [Related]
4. Comparative effects of trazodone and tricyclic antidepressants on uptake of selected neurotransmitters by isolated rat brain synaptosomes.
Riblet LA; Gatewood CF; Mayol RF
Psychopharmacology (Berl); 1979 May; 63(2):99-101. PubMed ID: 38478
[TBL] [Abstract][Full Text] [Related]
5. d-Amphetamine as a releaser or reuptake inhibitor of biogenic amines in synaptosomes.
Raiteri M; Bertollini A; Angelini F; Levi G
Eur J Pharmacol; 1975 Nov; 34(1):189-95. PubMed ID: 1234761
[TBL] [Abstract][Full Text] [Related]
6. Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: most antidepressants selectively block norepinephrine uptake.
Richelson E; Pfenning M
Eur J Pharmacol; 1984 Sep; 104(3-4):277-86. PubMed ID: 6499924
[TBL] [Abstract][Full Text] [Related]
7. Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]monoamines into synaptosomes from different regions of rat brain.
Steele TD; Nichols DE; Yim GK
Biochem Pharmacol; 1987 Jul; 36(14):2297-303. PubMed ID: 2886126
[TBL] [Abstract][Full Text] [Related]
8. Proceedings: The effect of mepiprazole on the uptake of norepinephrine, dopamine and serotonin into rat brain synaptosomes.
Placheta P; Singer E; Krivanek W; Hertting G
Naunyn Schmiedebergs Arch Pharmacol; 1975; 287 Suppl():R4. PubMed ID: 1143436
[No Abstract] [Full Text] [Related]
9. The effects of ibogaine on dopamine and serotonin transport in rat brain synaptosomes.
Wells GB; Lopez MC; Tanaka JC
Brain Res Bull; 1999 Apr; 48(6):641-7. PubMed ID: 10386845
[TBL] [Abstract][Full Text] [Related]
10. Comparative actions of monomethoxyamphetamines on the release and uptake of biogenic amines in brain tissue.
Tseng LF; Menon MK; Loh HH
J Pharmacol Exp Ther; 1976 May; 197(2):263-71. PubMed ID: 1271280
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of (3H)-dopamine uptake into rat brain synaptosomes by the new non-tricyclic antidepressants, FS32 and FS97.
Koide T; Uyemura K
Eur J Pharmacol; 1980 Mar; 62(2-3):147-55. PubMed ID: 7379837
[TBL] [Abstract][Full Text] [Related]
12. [The influence of mepiprazol on monoamine metabolism in the rat CNS: demonstration of reduced norepinephrine activity and simultaneously enhanced serotonin and dopamine activities (author's transl)].
Seyfried C; Nowak H; Wolf HP
Arzneimittelforschung; 1976; 26(6):1088-90. PubMed ID: 989382
[TBL] [Abstract][Full Text] [Related]
13. A new selective inhibitor for uptake of serotonin into synaptosomes of rat brain: 3-(p-trifluoromethylphenoxy). N-methyl-3-phenylpropylamine.
Wong DT; Bymaster FP; Horng JS; Molloy BB
J Pharmacol Exp Ther; 1975 Jun; 193(3):804-11. PubMed ID: 1151730
[TBL] [Abstract][Full Text] [Related]
14. GBR 12783, a potent and selective inhibitor of dopamine uptake: biochemical studies in vivo and ex vivo.
Bonnet JJ; Costentin J
Eur J Pharmacol; 1986 Feb; 121(2):199-209. PubMed ID: 3754516
[TBL] [Abstract][Full Text] [Related]
15. Regional changes in monoamine content and uptake of the rat brain during postnatal development.
Nomura Y; Naitoh F; Segawa T
Brain Res; 1976 Jan; 101(2):305-15. PubMed ID: 1244975
[TBL] [Abstract][Full Text] [Related]
16. Effect of sympathomimetic amines on the synaptosomal transport of noradrenaline, dopamine and 5-hydroxytryptamine.
Raiteri M; Del Carmine R; Bertollini A; Levi G
Eur J Pharmacol; 1977 Jan; 41(2):133-43. PubMed ID: 832672
[TBL] [Abstract][Full Text] [Related]
17. Uptake inhibition of biogenic amines by newer antidepressant drugs: relevance to the dopamine hypothesis of depression.
Randrup A; Braestrup C
Psychopharmacology (Berl); 1977 Aug; 53(3):309-14. PubMed ID: 408861
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of in vitro amine uptake into rat brain synaptosomes after in vivo administration of antidepressants.
Manias B; Taylor DA
Eur J Pharmacol; 1983 Nov; 95(3-4):305-9. PubMed ID: 6653676
[TBL] [Abstract][Full Text] [Related]
19. Differential binding of antidepressants to noradrenaline and serotonin transport sites in central nerve endings.
Raiteri M; Del Carmine R; Cervoni AM; Levi G
Eur J Pharmacol; 1979 Aug; 57(4):407-16. PubMed ID: 488170
[TBL] [Abstract][Full Text] [Related]
20. Irreversible binding and recovery of the norepinephrine uptake system using an alkylating derivative of norepinephrine.
Baker SP; Standifer KM; Kalberg CJ; Pitha J; Sumners C
J Neurochem; 1988 Apr; 50(4):1044-52. PubMed ID: 2894406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
